FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898049219> ?p ?o ?g. }

• W2898049219 endingPage "45" @default.
• W2898049219 startingPage "34" @default.
• W2898049219 abstract "Therapeutic drug monitoring (TDM) uses drug concentrations, primarily from plasma, to optimize drug dosing. Optimisation of drug dosing may improve treatment outcomes, reduce toxicity and reduce the risk of acquired drug resistance. The aim of this narrative review is to outline and discuss the challenges of developing multi-analyte assays for anti-tuberculosis (TB) drugs using liquid chromatography-tandem mass spectrometry (LC-MS/MS) by reviewing the existing literature in the field. Compared to other analytical methods, LC-MS/MS offers higher sensitivity and selectivity while requiring relatively low sample volumes. Additionally, multi-analyte assays are easier to perform since adequate separation and short run times are possible even when non-selective sample preparation techniques are used. However, challenges still exist, especially when optimizing LC separation techniques for assays that include analytes with differing chemical properties. Here, we have identified seven multi-analyte assays for first-line anti-TB drugs that use various solvents for sample preparation and mobile phase separation. Only two multi-analyte assays for second-line anti-TB drugs were identified (including either nine or 20 analytes), with each using different protein precipitation methods, mobile phases and columns. The 20 analyte assay did not include bedaquiline, delamanid, meropenem or imipenem. For these drugs, other assays with similar methodologies were identified that could be incorporated in the development of a future comprehensive multi-analyte assay. TDM is a powerful methodology for monitoring patient's individual treatments in TB programmes, but its implementation will require different approaches depending on available resources. Since TB is most-prevalent in low- and middle-income countries where resources are scarce, a patient-centred approach using sampling methods other than large volume blood draws, such as dried blood spots or saliva collection, could facilitate its adoption and use. Regardless of the methodology of collection and analysis, it will be critical that laboratory proficiency programmes are in place to ensure adequate quality control. It is our intent that the information contained in this review will contribute to the process of assembling comprehensive multiplexed assays for the dynamic monitoring of anti-TB drug treatment in affected individuals." @default.
• W2898049219 created "2018-10-26" @default.
• W2898049219 creator A5000820066 @default.
• W2898049219 creator A5004578527 @default.
• W2898049219 creator A5017350057 @default.
• W2898049219 creator A5018163150 @default.
• W2898049219 creator A5023545883 @default.
• W2898049219 creator A5027445922 @default.
• W2898049219 creator A5029393839 @default.
• W2898049219 creator A5030569559 @default.
• W2898049219 creator A5034027868 @default.
• W2898049219 creator A5064588888 @default.
• W2898049219 creator A5085640221 @default.
• W2898049219 creator A5089218136 @default.
• W2898049219 date "2019-09-01" @default.
• W2898049219 modified "2023-10-01" @default.
• W2898049219 title "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" @default.
• W2898049219 cites W1063344538 @default.
• W2898049219 cites W1771908393 @default.
• W2898049219 cites W1971210149 @default.
• W2898049219 cites W1971623624 @default.
• W2898049219 cites W1973380053 @default.
• W2898049219 cites W1985678879 @default.
• W2898049219 cites W1993156441 @default.
• W2898049219 cites W2001488455 @default.
• W2898049219 cites W2002883043 @default.
• W2898049219 cites W2010769187 @default.
• W2898049219 cites W2019883403 @default.
• W2898049219 cites W2027951201 @default.
• W2898049219 cites W2042516926 @default.
• W2898049219 cites W2049496729 @default.
• W2898049219 cites W2062129541 @default.
• W2898049219 cites W2064018724 @default.
• W2898049219 cites W2064213747 @default.
• W2898049219 cites W2076191577 @default.
• W2898049219 cites W2090659484 @default.
• W2898049219 cites W2095750649 @default.
• W2898049219 cites W2097133372 @default.
• W2898049219 cites W2098582744 @default.
• W2898049219 cites W2098793988 @default.
• W2898049219 cites W2103327802 @default.
• W2898049219 cites W2107834145 @default.
• W2898049219 cites W2108960489 @default.
• W2898049219 cites W2113051108 @default.
• W2898049219 cites W2118654266 @default.
• W2898049219 cites W2119239704 @default.
• W2898049219 cites W2120343562 @default.
• W2898049219 cites W2122682841 @default.
• W2898049219 cites W2133530219 @default.
• W2898049219 cites W2145257685 @default.
• W2898049219 cites W2147213334 @default.
• W2898049219 cites W2147238867 @default.
• W2898049219 cites W2154552906 @default.
• W2898049219 cites W2161641226 @default.
• W2898049219 cites W2164091066 @default.
• W2898049219 cites W2170012142 @default.
• W2898049219 cites W2177317049 @default.
• W2898049219 cites W2219675891 @default.
• W2898049219 cites W2278516944 @default.
• W2898049219 cites W2284722179 @default.
• W2898049219 cites W2285757988 @default.
• W2898049219 cites W2295478175 @default.
• W2898049219 cites W2307974079 @default.
• W2898049219 cites W2333169010 @default.
• W2898049219 cites W2343006376 @default.
• W2898049219 cites W2347047707 @default.
• W2898049219 cites W2469070945 @default.
• W2898049219 cites W2513063996 @default.
• W2898049219 cites W2516938750 @default.
• W2898049219 cites W2528055241 @default.
• W2898049219 cites W2530722318 @default.
• W2898049219 cites W2569758680 @default.
• W2898049219 cites W2583522215 @default.
• W2898049219 cites W2606465225 @default.
• W2898049219 cites W2616813217 @default.
• W2898049219 cites W2743897063 @default.
• W2898049219 cites W2754298368 @default.
• W2898049219 cites W2767671107 @default.
• W2898049219 cites W2770480067 @default.
• W2898049219 cites W2781580739 @default.
• W2898049219 cites W2783110166 @default.
• W2898049219 cites W2808510850 @default.
• W2898049219 cites W2859364562 @default.
• W2898049219 cites W2886035859 @default.
• W2898049219 cites W2904314211 @default.
• W2898049219 cites W2904326384 @default.
• W2898049219 doi "https://doi.org/10.1016/j.clinms.2018.10.002" @default.
• W2898049219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34934812" @default.
• W2898049219 hasPublicationYear "2019" @default.
• W2898049219 type Work @default.
• W2898049219 sameAs 2898049219 @default.
• W2898049219 citedByCount "15" @default.
• W2898049219 countsByYear W28980492192019 @default.
• W2898049219 countsByYear W28980492192020 @default.
• W2898049219 countsByYear W28980492192022 @default.
• W2898049219 countsByYear W28980492192023 @default.
• W2898049219 crossrefType "journal-article" @default.
• W2898049219 hasAuthorship W2898049219A5000820066 @default.

• next